| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/12/2013 | EP2601840A2 Chemical and biological agents for the control of molluscs |
| 06/12/2013 | EP2601181A1 Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl]acetamide and the use thereof as bradykinin b1 receptor antagonists |
| 06/12/2013 | CN1921885B Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 06/12/2013 | CN103145953A Anacardol glycidyl ether modified mixed amine hardener and preparation method thereof |
| 06/12/2013 | CN103145952A Cashew nut shell oil-modified mixed-amine curing agent and preparation method |
| 06/12/2013 | CN103145663A (S)-2-(2,3-dihydrobenzofuran-3-radical) acetic acid derivative as well as preparation method and application thereof in medicines |
| 06/12/2013 | CN102336723B Preparation method of L-chloperastine fendizoic acid |
| 06/12/2013 | CN101600683B Therapeutic compounds |
| 06/12/2013 | CN101410370B Selective hydroxamate based MMP inhibitors |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/12/2013 | CN101258138B Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands |
| 06/11/2013 | US8461335 Acid gas scrubbing composition |
| 06/11/2013 | CA2577837C Diarylsulfones as 5-ht2a antagonists |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/06/2013 | WO2013082490A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | WO2013082210A1 Anticoagulant reversal agents |
| 06/06/2013 | WO2013080095A1 Process for the preparation of agomelatine |
| 06/06/2013 | WO2013080049A2 A process for the manufacture of chiral catalysts and their salts |
| 06/06/2013 | WO2013024040A3 Tnf superfamily trimerization inhibitors |
| 06/06/2013 | US20130144057 (meth)acrylic acid ester, activation energy ray curing composition, and inkjet recording ink |
| 06/06/2013 | US20130143858 Compounds and their use as ikach blockers |
| 06/06/2013 | CA2856839A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | CA2856540A1 Anticoagulant reversal agents |
| 06/06/2013 | CA2855751A1 A process for the manufacture of chiral catalysts and their salts |
| 06/05/2013 | EP2598499A2 Process for the preparation of imatinib mesylate |
| 06/05/2013 | EP2598483A1 Ampk-activating heterocyclic compounds and methods for using the same |
| 06/05/2013 | CN103140481A Solid forms comprising a cyclopropyl amide derivative |
| 06/05/2013 | CN103140474A Napht- 2 -ylacetic acid derivatives to treat aids |
| 06/05/2013 | CN103130746A Flunarizine derivative, preparation method and use thereof |
| 06/05/2013 | CN103130745A Diaryl-piperazines compound and medical application thereof |
| 06/05/2013 | CN103130686A N,N'-asymmetric diayl substitution urea compound and preparation method and purpose thereof |
| 06/05/2013 | CN103130653A Method for continuous production of vinylamine by tubular reactor and device |
| 06/05/2013 | CN103130651A Method for producing vinylamine by kettle-type reactor |
| 06/05/2013 | CN101654416B N-[3-nitro-4-methyl-phenyl]-4-aldehyde group-benzamide and preparation method thereof as well as preparation method of derivatives thereof |
| 06/05/2013 | CN101563351B Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 06/05/2013 | CN101460445B Process for the preparation of an amine |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455476 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/30/2013 | WO2013077949A1 Amine sulfide scavengers, methods of using, and methods of making |
| 05/30/2013 | WO2013075510A1 L-setastine hydrochloride and preparation method therefor |
| 05/30/2013 | US20130137746 Indane estrogen receptor modulators and uses thereof |
| 05/30/2013 | US20130137690 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 05/29/2013 | EP2597084A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 05/29/2013 | EP2597083A2 Selective hydroxamate based MMP inhibitors |
| 05/29/2013 | EP2595620A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 05/29/2013 | CN103122004A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122003A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122002A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103121978A Method for preparing N-methylmorpholine |
| 05/29/2013 | CN102050801B Method for preparing arylpiperazines derivative optical isomer |
| 05/29/2013 | CN102050800B Method for preparing optical isomers of 1-butyl-2-hydroxyarylalkanol piperazine derivative |
| 05/29/2013 | CN101774874B N-arylating method using pyrrole-2-hydrazide compound as ligand in aqueous phase system |
| 05/28/2013 | US8450325 Methods for reducing the recurrence of cardiac arrhythmia |
| 05/28/2013 | US8450312 Micronized tanaproget, compositions, and methods of preparing the same |
| 05/28/2013 | US8450303 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/28/2013 | CA2582760C Modulators of hcv replication |
| 05/28/2013 | CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives |
| 05/28/2013 | CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/23/2013 | WO2013073985A1 Thermochromic device (alternative embodiments) |
| 05/23/2013 | WO2013042138A3 Process for preparation of triazole antifungal drug, its intermediates and polymorphs thereof |
| 05/23/2013 | US20130131339 Process for Producing SN-Comprising Catalysts |
| 05/23/2013 | US20130131034 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 05/22/2013 | EP2594565A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594564A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594563A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594562A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2593424A1 Novel arylamide derivatives having antiandrogenic properties |
| 05/22/2013 | CN1993339B Aromatic compounds |
| 05/22/2013 | CN103113618A Method for preparing cold-recycling asphalt emulsification additive |
| 05/22/2013 | CN103113324A Preparation method of N-sulfonyl substituted tetrahydropyrrole compound |
| 05/22/2013 | CN103113323A Preparation method of lasofoxifene tartrate intermediate compound |
| 05/22/2013 | CN103113247A Method for preparing amino-acid ester |
| 05/22/2013 | CN102295623B Method for preparing N-acetylmorpholine by using ketene |
| 05/21/2013 | US8445683 Porphyrin compounds comprising one or more pyridone moieties |
| 05/21/2013 | US8445492 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds |
| 05/21/2013 | CA2573223C Aromatic compound |
| 05/16/2013 | WO2013068785A1 Indanone and indandione derivatives and heterocyclic analogs |
| 05/16/2013 | US20130123243 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| 05/15/2013 | CN103108866A Cyclohexane derivative compound |
| 05/15/2013 | CN103102332A Chalcone compound containing piperazine ring and preparation and application thereof |
| 05/15/2013 | CN103102331A Pharmaceutical application of chalcone compound containing piperazine ring |
| 05/15/2013 | CN101842346B Method for producing amines from sugar alcohols |
| 05/10/2013 | WO2013065059A1 Process for preparation of n,n-di substituted carboxamides |
| 05/10/2013 | WO2013064538A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/10/2013 | WO2013019655A3 Vimentin as a biomarker for the progression of myeloproliferative neoplasms |
| 05/10/2013 | CA2853006A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/09/2013 | US20130116318 Enzyme Inhibitors |
| 05/09/2013 | US20130116290 Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in Mammals |
| 05/09/2013 | US20130116256 Hexenone compounds and medical use thereof |
| 05/09/2013 | US20130116227 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 05/09/2013 | US20130115163 Synthesis of mse-framework type molecular sieves |
| 05/08/2013 | EP2588450A1 Napht- 2 -ylacetic acid derivatives to treat aids |
| 05/08/2013 | CN103097354A Substituted benzamide compounds |
| 05/08/2013 | CN103087085A Preparation method for methylaluminoxane, titanium dioxide, white carbon black and phosgene and application of carbon tetrachloride and hexachloroethane |
| 05/08/2013 | CN103087009A Carboxylic acid derivative compound and preparation method and application thereof |
| 05/08/2013 | CN103087008A Method for preparing Mepigtlat-chloride |
| 05/08/2013 | CN102234255B Preparation method of 2-morpholinoisobornane-10-thoil and intermediates formed thereby |
| 05/08/2013 | CN101796042B Novel compounds 951: a biphenyloxypropanoic acid as CRTH2 modulator and intermediates |
| 05/07/2013 | CA2551956C Selective estrogen receptor modulators for the treatment of vasomotor symptoms |